ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website
ENHERTU (en-HER-too) is a prescription medicine used to treat adults who have: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by …
Enhertu: Uses, Dosage, Side Effects, Warnings - Drugs.com
3 天之前 · Enhertu is a treatment for breast cancer, advanced stomach cancer, non-small cell lung cancer, and solid tumors with HER2 gene mutations in certain patients. Enhertu may help …
“神药”来了！德曲妥珠单抗ENHERTU（DS-8201）获批国内HER2 …
2023年3月7日 · 注射用德曲妥珠单抗，由 阿斯利康 和第一三共联合开发，商品名：优赫得，通用名：Fam-Trastuzumabderuxtecan（T-DXd），医学名：德曲妥珠单抗（ENHERTU），科研 …
Enhertu approved in the US as first HER2-directed therapy for …
2025年1月27日 · Based on DESTINY-Breast06 Phase III trial results which showed Enhertu demonstrated superiority vs. chemotherapy with a median progression-free survival of more …
ENHERTU® Approved in the U.S. as First HER2 Directed Therapy …
2025年1月27日 · ENHERTU (5.4 mg/kg) is approved in more than 75 countries worldwide for the treatment of adult patients with unresectable or metastatic HER2 positive …
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the …
2025年1月27日 · AstraZeneca and Daiichi Sankyo’s ENHERTU ® (fam-trastuzumab deruxtecan-nxki) has been approved in the US for the treatment of adult patients with unresectable or …
ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Official HCP Site
ENHERTU is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with:
FDA grants accelerated approval to fam-trastuzumab deruxtecan …
On April 5, 2024, the Food and Drug Administration granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with …
ENHERTU is indicated for the treatment of adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer who have received a prior chemotherapy in the …
ENHERTU® (fam-trastuzumab deruxtecan-nxki) | About ENHERTU
What is ENHERTU? ENHERTU is a prescription medicine used to treat adults who have: Human epidermal growth factor receptor 2 (HER2)-low breast cancer that cannot be removed by …